Evidence map›Paper›PMID 33118851›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences

Complex Metal Ions: Neuropsychiatric and Imaging Features.

James R Bateman, Katherine H Taber, Robin A Hurley

Abstract read
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James R BatemanThe Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and the Research and Academic Affairs Service Line, W.G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (Bateman, Taber, Hurley); Departments of Neurology and Psychiatry, Wake Forest School of Medicine, Winston-Salem, N.C. (Bateman); Departments of Psychiatry and Radiology, Wake Forest School of Medicine, Winston-Salem, N.C., and the Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston (Hurley); and Division of Biomedical Sciences, Via College of Osteopathic Medicine, Blacksburg, Va. and Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston (Taber).
Katherine H TaberThe Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and the Research and Academic Affairs Service Line, W.G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (Bateman, Taber, Hurley); Departments of Neurology and Psychiatry, Wake Forest School of Medicine, Winston-Salem, N.C. (Bateman); Departments of Psychiatry and Radiology, Wake Forest School of Medicine, Winston-Salem, N.C., and the Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston (Hurley); and Division of Biomedical Sciences, Via College of Osteopathic Medicine, Blacksburg, Va. and Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston (Taber).
Robin A HurleyThe Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and the Research and Academic Affairs Service Line, W.G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (Bateman, Taber, Hurley); Departments of Neurology and Psychiatry, Wake Forest School of Medicine, Winston-Salem, N.C. (Bateman); Departments of Psychiatry and Radiology, Wake Forest School of Medicine, Winston-Salem, N.C., and the Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston (Hurley); and Division of Biomedical Sciences, Via College of Osteopathic Medicine, Blacksburg, Va. and Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston (Taber).

Funding

Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW · 2016 to 2020
$12.2M
NIA NIH HHS P30 AG049638
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neurotoxicity SyndromesAntineoplastic AgentsCentral Nervous SystemCisplatinContrast MediaCyanidesGadoliniumHumansMagnetic Resonance ImagingNeuroimagingAntineoplastic AgentsCisplatinContrast MediaCyanidesGadoliniumCTMetal IonsMRINeuroimaging

Identifiers

PMID33118851
PMCPMC9808918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.